GlaxoSmithKline Pharmaceuticals Limited (GLAXO.BO)

INR 2306.25

(-1.23%)

Inventory Summary of GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited's latest annual inventory in 2023 was 5.33 Billion INR , up 16.08% from previous year.
GlaxoSmithKline Pharmaceuticals Limited's latest quarterly inventory in 2024 Q2 was 5.17 Billion INR , down 0.0% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported annual inventory of 4.59 Billion INR in 2022, down -13.98% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported annual inventory of 5.34 Billion INR in 2021, down -2.2% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported quarterly inventory of 5.17 Billion INR for 2024 Q2, down 0.0% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported quarterly inventory of 5.33 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Historical Annual Inventory of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Year	Inventory	Inventory Growth
2023	5.33 Billion INR	16.08%
2022	4.59 Billion INR	-13.98%
2021	5.34 Billion INR	-2.2%
2020	5.46 Billion INR	13.18%
2019	4.83 Billion INR	-0.71%
2018	4.86 Billion INR	-2.74%
2017	5 Billion INR	17.47%
2016	4.25 Billion INR	-19.03%
2015	5.25 Billion INR	40.01%
2014	3.75 Billion INR	8.25%
2013	3.46 Billion INR	21.68%
2012	2.85 Billion INR	-14.48%
2011	3.33 Billion INR	16.77%
2010	2.85 Billion INR	10.98%
2009	2.57 Billion INR	10.44%
2008	2.32 Billion INR	10.31%
2007	2.11 Billion INR	-14.42%
2006	2.46 Billion INR	11.01%
2005	2.22 Billion INR	-3.51%
2004	2.3 Billion INR	0.0%

Year	Inventory	Inventory Growth
2024 Q1	- INR	-100.0%
2024 Q2	5.17 Billion INR	0.0%
2023 Q4	5.33 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q2	5.37 Billion INR	0.0%
2023 FY	5.33 Billion INR	16.08%
2023 Q3	- INR	-100.0%
2022 Q4	4.59 Billion INR	0.0%
2022 FY	4.59 Billion INR	-13.98%
2022 Q1	- INR	-100.0%
2022 Q2	6.46 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 FY	5.34 Billion INR	-2.2%
2021 Q2	5.35 Billion INR	0.0%
2021 Q4	5.34 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 FY	5.46 Billion INR	13.18%
2020 Q4	5.46 Billion INR	0.0%
2020 Q2	5 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2019 Q4	4.83 Billion INR	0.0%
2019 FY	4.83 Billion INR	-0.71%
2019 Q1	- INR	-100.0%
2019 Q2	4.57 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2018 Q4	4.86 Billion INR	0.0%
2018 Q1	- INR	0.0%
2018 FY	4.86 Billion INR	-2.74%
2017 FY	5 Billion INR	17.47%
2016 FY	4.25 Billion INR	-19.03%
2015 FY	5.25 Billion INR	40.01%
2014 FY	3.75 Billion INR	8.25%
2013 FY	3.46 Billion INR	21.68%
2012 FY	2.85 Billion INR	-14.48%
2011 FY	3.33 Billion INR	16.77%
2010 FY	2.85 Billion INR	10.98%
2009 FY	2.57 Billion INR	10.44%
2008 FY	2.32 Billion INR	10.31%
2007 FY	2.11 Billion INR	-14.42%
2006 FY	2.46 Billion INR	11.01%
2005 FY	2.22 Billion INR	-3.51%
2004 FY	2.3 Billion INR	0.0%

Peer Inventory Comparison of GlaxoSmithKline Pharmaceuticals Limited

Name	Inventory	Inventory Difference
Abbott India Limited	6.19 Billion INR	13.827%
Cipla Limited	52.37 Billion INR	89.807%
Gland Pharma Limited	16.55 Billion INR	67.744%
Kopran Limited	1.38 Billion INR	-285.534%
Marksans Pharma Limited	6.17 Billion INR	13.599%
NGL Fine-Chem Limited	433.03 Million INR	-1132.956%
Pfizer Limited	4.33 Billion INR	-23.109%
Sanofi India Limited	6.63 Billion INR	19.567%
SMS Pharmaceuticals Limited	2.33 Billion INR	-128.463%